Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
89.65
+2.32 (2.66%)
At close: Dec 5, 2025, 4:00 PM EST
89.00
-0.65 (-0.73%)
After-hours: Dec 5, 2025, 6:37 PM EST
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $5.60 billion as of December 5, 2025. Its market cap has increased by 143.30% in one year.
Market Cap
5.60B
Enterprise Value
4.94B
1-Year Change
143.30%
Ranking
Category
Stock Price
$89.65
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $5.60B, an increase of 3,167.95%. That is a compound annual growth rate of 45.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.60B | 143.62% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |